Pioneering early disease detection from brain MRI using AI
Why choose Neurivyx
Early Detection: Identifying biomarkers before symptoms appear.
AI-Powered Analysis: High accuracy in detecting subtle abnormalities.
Clinical Insights: Actionable reports for clinicians.
Our Team
Associate Professor Baptiste Couvy-Duchesne
Research leader
Technical expertise in AI for health and brain imaging.Scientific leadership and project management.Best Rising Stars of Science in the World 2025/2026 (top 1,000 worldwide, top 50 in Australia).
Dr Shafali Gupta
Business Development Officer, QIMR Berghofer
Startup experience across both software and hardware ventures.Listed among the Top 100 Innovators by the Australian Business Review.Australian Government Global Talent Finalist.Winner of the Nespresso StartCup Challenge.
Alastair Collett
Clinical PartnerMRI National Modality Lead for Qscan GroupNeurivyx clinical partner.AI implementation in clinics.Advanced imaging techniques incl. whole-body MRI. Clinical trial setups.Experience with all MR vendors.
Professor Sarah Medland
Scientific AdvisorLeading researcher in mental health genetics
and brain functionExpertise in treatment response, women’s
health, and translational genomics.Strong track record in translating research into clinical impact.